These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 18495311)
1. Evaluation of the antibradykinetic actions of 5-HT1A agonists using the mouse pole test. Ohno Y; Shimizu S; Imaki J; Ishihara S; Sofue N; Sasa M; Kawai Y Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jul; 32(5):1302-7. PubMed ID: 18495311 [TBL] [Abstract][Full Text] [Related]
2. Anticataleptic 8-OH-DPAT preferentially counteracts with haloperidol-induced Fos expression in the dorsolateral striatum and the core region of the nucleus accumbens. Ohno Y; Shimizu S; Imaki J; Ishihara S; Sofue N; Sasa M; Kawai Y Neuropharmacology; 2008 Oct; 55(5):717-23. PubMed ID: 18585397 [TBL] [Abstract][Full Text] [Related]
3. Tandospirone, a 5-HT1A agonist, ameliorates movement disorder via non-dopaminergic systems in rats with unilateral 6-hydroxydopamine-generated lesions. Matsubara K; Shimizu K; Suno M; Ogawa K; Awaya T; Yamada T; Noda T; Satomi M; Ohtaki K; Chiba K; Tasaki Y; Shiono H Brain Res; 2006 Sep; 1112(1):126-33. PubMed ID: 16884702 [TBL] [Abstract][Full Text] [Related]
4. Therapeutic potential of alpha2 adrenoceptor antagonism for antipsychotic-induced extrapyramidal motor disorders. Imaki J; Mae Y; Shimizu S; Ohno Y Neurosci Lett; 2009 Apr; 454(2):143-7. PubMed ID: 19429072 [TBL] [Abstract][Full Text] [Related]
5. Cellular and behavioral effects of 5-HT1A receptor agonist 8-OH-DPAT in a rat model of levodopa-induced motor complications. Ba M; Kong M; Ma G; Yang H; Lu G; Chen S; Liu Z Brain Res; 2007 Jan; 1127(1):177-84. PubMed ID: 17113046 [TBL] [Abstract][Full Text] [Related]
6. Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the antipsychotic drug perospirone: role of serotonin 5-HT1A receptors. Hagiwara H; Fujita Y; Ishima T; Kunitachi S; Shirayama Y; Iyo M; Hashimoto K Eur Neuropsychopharmacol; 2008 Jun; 18(6):448-54. PubMed ID: 18164909 [TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo characterization of F-97013-GD, a partial 5-HT1A agonist with antipsychotic- and antiparkinsonian-like properties. Zazpe A; Artaiz I; Innerárity A; Del Olmo E; Castro E; Labeaga L; Pazos A; Orjales A Neuropharmacology; 2006 Jul; 51(1):129-40. PubMed ID: 16643965 [TBL] [Abstract][Full Text] [Related]
8. Role of cortical and striatal 5-HT1A receptors in alleviating antipsychotic-induced extrapyramidal disorders. Shimizu S; Tatara A; Imaki J; Ohno Y Prog Neuropsychopharmacol Biol Psychiatry; 2010 Aug; 34(6):877-81. PubMed ID: 20398719 [TBL] [Abstract][Full Text] [Related]
9. Evidence that the 5-HT1A autoreceptor is an important pharmacological target for the modulation of cocaine behavioral stimulant effects. Carey RJ; DePalma G; Damianopoulos E; Shanahan A; Müller CP; Huston JP Brain Res; 2005 Feb; 1034(1-2):162-71. PubMed ID: 15713268 [TBL] [Abstract][Full Text] [Related]
10. Effect of the postsynaptic 5-HT1A receptor antagonist MM-77 on stressed mice treated with 5-HT1A receptor agents. Alfredo BA; Ofir P Eur J Pharmacol; 2005 Jan; 508(1-3):155-8. PubMed ID: 15680266 [TBL] [Abstract][Full Text] [Related]
11. Involvement of 5-hydroxytryptamine1A receptors in Delta9-tetrahydrocannabinol-induced catalepsy-like immobilization in mice. Egashira N; Matsuda T; Koushi E; Mishima K; Iwasaki K; Shoyama Y; Fujiwara M Eur J Pharmacol; 2006 Nov; 550(1-3):117-22. PubMed ID: 17022969 [TBL] [Abstract][Full Text] [Related]
12. Serotonin(1A) receptor agonism in the expression of behavioral dopaminergic supersensitivity in subchronic haloperidol treated rats. Batool F; Haleem DJ Pak J Pharm Sci; 2008 Oct; 21(4):411-20. PubMed ID: 18930864 [TBL] [Abstract][Full Text] [Related]
13. Activation of septal 5-HT1A receptors alters spatial memory encoding, interferes with consolidation, but does not affect retrieval in rats subjected to a water-maze task. Koenig J; Cosquer B; Cassel JC Hippocampus; 2008; 18(1):99-118. PubMed ID: 17924524 [TBL] [Abstract][Full Text] [Related]
14. 5-HT1A receptors in the dorsal hippocampus mediate the anxiogenic effect induced by the stimulation of 5-HT neurons in the median raphe nucleus. Dos Santos L; de Andrade TG; Zangrossi Junior H Eur Neuropsychopharmacol; 2008 Apr; 18(4):286-94. PubMed ID: 17728111 [TBL] [Abstract][Full Text] [Related]
15. [Effect of 8-OH-DPAT on the depressive behavior and monoamine metabolism in the hippocampus of ovariectomized rats]. Fedotova IuO Eksp Klin Farmakol; 2006; 69(1):12-7. PubMed ID: 16579052 [TBL] [Abstract][Full Text] [Related]
16. Bidirectional modulation of classical fear conditioning in mice by 5-HT(1A) receptor ligands with contrasting intrinsic activities. Youn J; Misane I; Eriksson TM; Millan MJ; Ogren SO; Verhage M; Stiedl O Neuropharmacology; 2009; 57(5-6):567-76. PubMed ID: 19607850 [TBL] [Abstract][Full Text] [Related]
17. 8-Hydroxy-2-(di-n-propylamino)-tetralin inhibits food intake in fasted rats by an action at 5-HT1A receptors. Ebenezer IS; Arkle MJ; Tite RM Methods Find Exp Clin Pharmacol; 2007 May; 29(4):269-72. PubMed ID: 17609739 [TBL] [Abstract][Full Text] [Related]
18. [Tandospirone citrate, a selective 5-HT1A agonist, alleviates L-DOPA-induced dyskinesia in patients with Parkinson's disease]. Kannari K; Kurahashi K; Tomiyama M; Maeda T; Arai A; Baba M; Suda T; Matsunaga M No To Shinkei; 2002 Feb; 54(2):133-7. PubMed ID: 11889759 [TBL] [Abstract][Full Text] [Related]
19. Reversal of haloperidol-induced tardive vacuous chewing movements and supersensitive somatodendritic serotonergic response by buspirone in rats. Haleem DJ; Samad N; Haleem MA Pharmacol Biochem Behav; 2007 May; 87(1):115-21. PubMed ID: 17498786 [TBL] [Abstract][Full Text] [Related]
20. Effects of tandospirone, a 5-HT1A agonistic anxiolytic agent, on haloperidol-induced catalepsy and forebrain Fos expression in mice. Ohno Y; Shimizu S; Imaki J J Pharmacol Sci; 2009 Apr; 109(4):593-9. PubMed ID: 19352073 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]